Search
Halozyme Therapeutics Inc
HALOAdd to Watchlist
112.450USD
+2.770+2.53%
Close 09-18 16:00（ET）
12.84BMarket Cap
38.10P/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
+2.53%
5 Days
+4.90%
1 Month
+7.21%
6 Months
+76.67%
Year to Date
+67.09%
1 Year
+46.65%
Key Figures
109.720Open
112.660High
160.57KVolume
38.10P/E TTM
9.97P/E Dynamic
--Dividend TTM
0.14%Turnover Ratio
109.680Prev. Close
109.378Low
17.91MTurnover
28.92P/E Static
89.48P/B
0.00%Div Yield TTM
14.33%ROA
112.66052wk High
0.13Volume Ratio
444.09MNet Profit
114.04MShares
2.9559EPS TTM
0.88Beta
99.40%ROE
61.23052wk Low
2.82%Amplitude
77.40%Gross Margin
12.84BMarket Cap
14.15Reward/Risk
2.34%Risk Rate
Halozyme Therapeutics Inc's Score
0.15vs previous score
Forecast7.80
Financial Health8.36
Technical3.39
Valuation Dimensions9.10
Institutional Confidence10.00
Risk Assessment8.13
Media Coverage
Coverage Level
Very Low
Very High
Neutral
Analyst Rating
Halozyme Therapeutics Inc Technical Analysis
Technical Indicators
Buy
Summary
Buy
Moving Average
Strong buy
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
1.96/1.84
Revenue / Forecast
481.00M/407.49M
Halozyme Therapeutics Inc Profile
SectorPharmaceuticals
Ticker SymbolHALO
Number of employees350
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| BlackRock Institutional Trust Company, N.A. | 9.73% |
| Vanguard Capital Management, LLC | 4.44% |
| Vanguard Portfolio Management, LLC | 4.43% |
| State Street Investment Management (US) | 4.32% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 52.12% |
| Investment Advisor/Hedge Fund | 38.27% |
| Research Firm | 5.24% |
| Hedge Fund | 5.07% |
Related Instruments
+0.04%
-0.09%
-0.04%
-0.02%
-0.19%
-0.39%
+1.55%
-0.52%
+0.07%
+0.12%
+0.35%
-1.55%
-1.65%
-1.53%
-0.56%
-0.58%
-0.55%
-2.55%
-0.73%
-0.42%Popular Instruments
51734.000
-26.000 (-0.05%)
29664.700
+252.000 (+0.86%)
7659.100
+27.000 (+0.35%)
14420.000
+119.000 (+0.83%)
65079.000
+130.000 (+0.20%)
6230.800
-76.400 (-1.21%)
96.001
-1.985 (-2.03%)
336.130
-0.870 (-0.26%)
222.270
+2.930 (+1.34%)
4377.330
+36.350 (+0.84%)
FAQs
What is the current price of Halozyme Therapeutics Inc (HALO)?
The current price of Halozyme Therapeutics Inc (HALO) is 112.45.
What is the symbol of Halozyme Therapeutics Inc?
The ticker symbol of Halozyme Therapeutics Inc is HALO.
What is the 52-week high of Halozyme Therapeutics Inc?
The 52-week high of Halozyme Therapeutics Inc is 112.63.
What is the 52-week low of Halozyme Therapeutics Inc?
The 52-week low of Halozyme Therapeutics Inc is 61.23.
What is the market capitalization of Halozyme Therapeutics Inc?
The market capitalization of Halozyme Therapeutics Inc is 12.84B.
Is Halozyme Therapeutics Inc (HALO) currently rated as Buy, Hold, or Sell?
According to analysts, Halozyme Therapeutics Inc (HALO) has an overall rating of Buy, with a price target of 101.91.
What is the Earnings Per Share (EPS TTM) of Halozyme Therapeutics Inc (HALO)?
The Earnings Per Share (EPS TTM) of Halozyme Therapeutics Inc (HALO) is 2.96.